|
|
|
| home > white papers > The Importance of ADCC in Assessing Clinically Relevant Differences - Sartorius Stedim BioOutsource Ltd |
|
|
 WHITE PAPERS |
|
|
Sartorius Stedim BioOutsource Ltd
|
|
The Importance of ADCC in Assessing Clinically Relevant Differences
|
|
Biosimilars have caused a revolution in the development of biologic
drugs. The model for biosimilars is a combination of speed to market and
low cost; these are fundamental to any biosimilar development project.
The biosimilars pathway to approval is not always without difficulty,
biosimilars are still relatively new, and as each new applicant is
reviewed we are learning more and more about these molecules.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PCI’s Tredegar Site Announces Significant Expansion of Analytical Laboratories at its Center of Excellence for Contained Manufacturing
Philadelphia, USA- March 19, 2018. Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, UK.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: 2nd Quarter 2014
Synergy Research Group
The Ministry of Health of Russian Federation approved 194 new clinical
trials of all types including local and bioequivalence studies during
the 2nd Quarter of 2014 (3% less than at the same period of the last
year).
The main contribution to the total number of studies was
made by multinational multi-center clinical trials (MMCT) and the number
of these studies stayed the same as in Q2 2013 – 81 studies. The number
of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to
59 in Q2 2014, a 22% decrease from last year’s figure. The number of
local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical
trials in Q2 2014.
More info >> |
|
 |
Industry Events |
 |
3rd Annual Inhalation & Respiratory Drug Delivery Congress
8-9 May 2018, London, UK
Oxford Global are proud to present our hugely
popular 3rd Annual Inhalation & Respiratory Drug Delivery Congress, 8th –
9th May 2018, London, UK. Over 300 delegates representing
global pharmaceutical organisations, leading biotech companies and
internationally renowned academic institutions will gather for over 20
presentations and case studies focused on the key issues in inhalation and
respiratory drug delivery.
More info >> |
|
|
|
